Ghost Tree Capital, LLC Assembly Biosciences, Inc. Transaction History

Ghost Tree Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$19.05 - $36.45 $6.19 Million - $11.8 Million	-325,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$34.41 - $44.23 $3.1 Million - $3.98 Million	90,000 Added 38.3%	325,000 $12.1 Million
Q2 2018 Aug 14, 2018	BUY	$39.21 - $50.29 $3.33 Million - $4.27 Million	85,000 Added 56.67%	235,000 $9.21 Million
Q1 2018 May 15, 2018	BUY	$41.7 - $64.16 $6.26 Million - $9.62 Million	150,000 New	150,000 $7.37 Million

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.